Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00248560
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Barbara Ann Karmanos Cancer Institute 36
Testing effectiveness (Phase 2)Study completedNCT00083720
What this trial is testing

Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy

Who this might be right for
Colorectal NeoplasmsMetastasesNeoplasm
Eli Lilly and Company 87
Testing effectiveness (Phase 2)Study completedNCT00861120
What this trial is testing

Panitumumab and Pegylated Liposomal Doxorubicin for Platinum-Resistant Epithelial Ovarian Cancer With KRAS Wild-type

Who this might be right for
Epithelial Ovarian Cancer
Vejle Hospital 33
Testing effectiveness (Phase 2)Ended earlyNCT02853162
What this trial is testing

Ablative tReatment of Inoperable REnal Cell Carcinoma Using STereotactic Body Radiotherapy (ARREST-study)

Who this might be right for
Renal Cell Carcinoma
UMC Utrecht 30
Testing effectiveness (Phase 2)Looking for participantsNCT06445062
What this trial is testing

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Who this might be right for
Colorectal CancerCRCPancreatic Ductal Adenocarcinoma+3 more
Revolution Medicines, Inc. 1,130
Not applicableEnrolling By InvitationNCT05212103
What this trial is testing

PET Imaging of Cancer Patients Using 68Ga-DOTA-Siglec-9

Who this might be right for
Acute Myeloid LeukemiaMelanomaNon Small Cell Lung Cancer
Turku University Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT04789486
What this trial is testing

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

Who this might be right for
Non-small Cell Lung CancerAdvanced Pancreatic AdenocarcinomaUnresectable Pancreatic Cancer+1 more
Dana-Farber Cancer Institute 100
Large-scale testing (Phase 3)Looking for participantsNCT07481786
What this trial is testing

Bevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases

Who this might be right for
Lung AdenocarcinomaBrain MetastasesRadiotherapy, Intensity-Modulated+2 more
Sun Yat-sen University 220
Not applicableLooking for participantsNCT07704970
What this trial is testing

QLESP Block for Pain Control in Robotic Partial Nephrectomy

Who this might be right for
Renal Cell Carcinoma (Kidney Cancer)Postoperative PainNerve Block
Huazhong University of Science and Technology 120
Not applicableWithdrawnNCT00084370
What this trial is testing

Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy

Who this might be right for
brca1 Mutation Carrierbrca2 Mutation CarrierOvarian Cancer
University of Alabama at Birmingham
Early research (Phase 1)Study completedNCT00217373
What this trial is testing

Vaccine Therapy, GM-CSF, and Interferon Alfa-2b in Treating Patients With Locally Advanced or Metastatic Cancer That Expresses Carcinoembryonic Antigen (CEA)

Who this might be right for
Adult Solid Neoplasm
National Cancer Institute (NCI) 33
Not applicableActive Not RecruitingNCT04634617
What this trial is testing

Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors

Who this might be right for
Endometrial CarcinomaMalignant Uterine NeoplasmUterine Corpus Cancer+1 more
M.D. Anderson Cancer Center 310
Not applicableStudy completedNCT02778191
What this trial is testing

Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
University Medical Center Groningen 413
Testing effectiveness (Phase 2)UnknownNCT05024318
What this trial is testing

NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma, Clear Cell, Somatic
Peter MacCallum Cancer Centre, Australia 20
Testing effectiveness (Phase 2)Ended earlyNCT05583110
What this trial is testing

Efficacy and Safety of the Combination of Trastuzumab Plus TUCAtinib Plus viNorelbine in Patients With HER2-positive Non-resectable Locally Advanced or Metastatic Breast Cancer

Who this might be right for
HER2-positive Metastatic Breast CancerLocally Advanced HER2 Positive Breast Carcinoma
Spanish Breast Cancer Research Group 13
Early research (Phase 1)Study completedNCT00370513
What this trial is testing

A Phase I Study of Pazopanib in Adult Patients With Liver Cancer

Who this might be right for
Carcinoma, Hepatocellular
GlaxoSmithKline 28
Not applicableStudy completedNCT05902260
What this trial is testing

The Effects of an Nutritional Intervention on PD-1 ICI in NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Joachim Aerts, MD PhD 51
Testing effectiveness (Phase 2)Looking for participantsNCT07269782
What this trial is testing

A Phase II Study to Evaluate the Efficacy and Safety of HLX43 + Serplulimab as Neoadjuvant Therapy in Subjects With NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Shanghai Henlius Biotech 60
Not applicableUnknownNCT05573282
What this trial is testing

Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Ended earlyNCT00200382
What this trial is testing

Phase II Study of Therapy With PS 341 in Patients With Advanced Stage Non Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Rasim Gucalp 27
Next Page